Nobel for Optogenetics Breakthrough Using Algae Protein — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Karl Deisseroth, Peter Hegemann, and Georg Nagel won the 2026 Nobel Prize in Physiology or Medicine for their work on light-gated ion channels and the development of optogenetics.
- Peter Hegemann and Georg Nagel discovered channelrhodopsin, a light-sensitive protein in the alga Chlamydomonas, which changes shape when exposed to light and allows ions to flow into the cell.
- Karl Deisseroth applied the discovery of channelrhodopsin to neuroscience by engineering nerve cells to express the protein, enabling them to be activated with light.
- Optogenetics allows precise control of specific brain cells in animals like mice, using light delivered via optical fibers, helping researchers study memory, movement, and sensation.
- In a 2012 experiment, researchers used optogenetics to reactivate fear memories in mice by stimulating specific neurons, demonstrating the technique’s power to manipulate memory.
- Optogenetics is now in early clinical trials for restoring vision in people with retinal degeneration by making surviving retinal cells light-sensitive.
- The Nobel Committee honored the discovery as a transformative example of how curiosity-driven research—such as studying how algae detect light—can lead to major medical advances.
Why it matters: Patients with retinal degeneration may gain partial vision restoration through ongoing optogenetics trials, while researchers now have a precise tool to dissect brain circuits involved in Parkinson’s, epilepsy, and memory. The award underscores that foundational biological research, even without immediate medical aims, can yield transformative therapies.
Ask SkimNews
